Results 31 to 40 of about 245,752 (174)
Nomenclature and clinical phenotypes of atopic dermatitis
Atopic dermatitis is a heterogeneous disease and resists classification. In this review, we discuss atopic dermatitis nomenclature and identify morphologic phenotypes, which will facilitate correct diagnoses and development of treatment strategies.
G. Girolomoni +7 more
semanticscholar +1 more source
Background Atopic dermatitis is known to be common among children, but there are few studies examining the epidemiology across the life course. In particular, there is a paucity of data on atopic dermatitis among older adults.
Leslie N Chan +7 more
semanticscholar +1 more source
Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis
Background Atopic dermatitis is the most common chronic inflammatory skin disease and presents a major public health burden worldwide. Recent observational studies revealed the potential association between atopic dermatitis with autoimmune disorders ...
Zhiyu Lu +7 more
semanticscholar +1 more source
Sensitizing agents found in children and adolescents with recalcitrant atopic dermatitis: a cross-sectional study with a pediatric battery [PDF]
Background Atopic dermatitis is the most common inflammatory skin disease in childhood and has an important impact on quality of life, especially severe cases or those that are recalcitrant to treatments. Sensitization to allergens with the potential for
Cristiane Almeida Soares Cattani +5 more
doaj +1 more source
Retrospective Study: Atopic Dermatitis in Childhood
Background: Atopic dermatitis is a chronically and relapsing inflammatory skin disease affecting individuals with atopic history or their families. Atopic dermatitis affects all ageswith percentage 15-30% in children and 1-2% in adults. Chronic pruritus,
Kristina Sihaloho, Diah Mira Indramaya
doaj +1 more source
Background Atopic dermatitis is a chronic inflammatory skin disease associated with pruritus. Skin affected by atopic dermatitis not only shows a high percentage of Staphylococcus aureus colonization, but corneal barrier dysfunction is also known to ...
Shuhei Kubota +8 more
doaj +1 more source
Tralokinumab, a fully human monoclonal antibody, specifically neutralizes interleukin‐13, a key cytokine driving peripheral inflammation in atopic dermatitis (AD). In phase II studies, tralokinumab combined with topical corticosteroids provided early and
A. Wollenberg +21 more
semanticscholar +1 more source
Prevalence and Incidence of Atopic Dermatitis: A Systematic Review
The primary objective of this study was to systematically review and analyse epidemiological studies of the prevalence and incidence of atopic dermatitis (AD) during childhood and adulthood, focusing on data from the 21st century.
Simon B A Bylund +3 more
semanticscholar +1 more source
Management of Children with Atopic Dermatitis: A Narrative Review
Context Atopic dermatitis is a chronic, relapsing skin disorder that affects all ages including infancy and childhood. There are many proved and unproved treatments for atopic dermatitis. Evidence Acquisition
Masoud Golpour +3 more
doaj +1 more source
Systemic Immunomodulatory Treatments for Atopic Dermatitis
Key Points Question What is the relative efficacy and harm of lebrikizumab, the most recently approved biologic medication for atopic dermatitis compared with other systemic treatments?
Aaron M Drucker +13 more
semanticscholar +1 more source

